Effect of eradication of Helicobacter pylorion genetic instabilities in gastric intestinal metaplasia

Alimentary Pharmacology and Therapeutics Symposium Series

Volumn 2, Issue 1, 2006, Pages 194-202

  Tanaka, A ^a   Watari, J ^a   Tanabe, H ^a   Maemoto, A ^a   Fujiya, M ^a   Ashida, T ^a   Das, K M ^b   Kohgo, Y ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE;

ADULT; AGED; CANCER INCIDENCE; CHRONIC GASTRITIS; CONFERENCE PAPER; CONTROLLED STUDY; ENDOSCOPIC MUCOSAL RESECTION; ERADICATION THERAPY; FEMALE; GENETIC VARIABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HETEROZYGOSITY LOSS; HUMAN; INTESTINE METAPLASIA; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH CANCER;

EID: 34247846173     PISSN: 17466334     EISSN: 17466342     Source Type: Journal    
DOI: 10.1111/j.1746-6342.2006.00045.x     Document Type: Conference Paper

References (51)

1. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990 66:2569 74.
2. Shipponen P, Hyvarinen H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol Suppl 1993 196:3 6.
3. Infection with Helicobacter pylori. In:IARC monographs on the evaluation of the carcinogenic risks to humans. Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. Lyon, France:International Agency for Research on Cancer, 1994:177 240.
4. Graham DY. Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterol 2000 35:90 7.
5. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001 345:784 9.
6. Correa P, Shiao YH. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994 54:1941s 3s.
7. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995 19:S37 43.
8. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988 48:3554 60.
9. Filipe MI, Munoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994 57:324 9.
10. Miehlke S, Hackelsberger A, Meining A, et al. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 1998 78:263 6.
11. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991 51:3075 9.
12. Lee HS, Lee BL, Kim SH, et al. Microsatellite instability in synchronous gastric carcinomas. Int J Cancer 2001 91:619 24.
13. Tokunaga E, Oki E, Oda S, et al. Frequency of microsatellite instability in breast cancer determined by high-resolution fluorescent microsatellite analysis. Oncology 2000 59:44 9.
14. Oda S, Oki E, Maehara Y, et al. Precise assessment of microsatellite instability using high resolution fluorescent microsatellite analysis. Nucleic Acids Res 1997 25:3415 20.
15. Shibata N, Watari J, Fujiya M, et al. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum Pathol 2003 34:32 40.
16. Semba S, Yokozaki H, Yamamoto S, et al. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer 1996 77:1620 7.
17. Ottini L, Palli D, Falchetti M, et al. Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 1997 57:4523 9.
18. Leung WK, Kim JJ, Kim JG, et al. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol 2000 156:537 43.
19. Kashiwagi K, Watanabe M, Ezaki T, et al. Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis. Br J Cancer 2000 82:1814 8.
20. Jin Z, Tamura G, Satoh M, et al. Absence of BAT-26 instability in gastric intestinal metaplasia. Pathol Int 2001 51:473 5.
21. Garay J, Bravo JC, Correa P, et al. Infrequency of microsatellite instability in complete type and incomplete gastric metaplasia. Hum Pathol 2004 35:102 6.
22. Choi SW, Park SW, Lee KY, Kim KM, Chung YJ, Rhyu MG. Fractional allelic loss in gastric carcinoma correlates with growth patterns. Oncogene 1998 17:2655 9.
23. Choi SW, Choi JR, Chung YJ, Kim KM, Rhyu MG. Prognostic implications of microsatellite genotypes in gastric carcinoma. Int J Cancer 2000 89:378 83.
24. Tamura G, Sato K, Akiyama S, et al. Molecular characterization of undifferentiated-type gastric carcinoma. Lab Invest 2001 81:593 8.
25. Kim KM, Kwon MS, Hong SJ, et al. Genetic classification of intestinal of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability. Virchows Arch 2003 443:491 500.
26. Jiao YF, Sugai T, Habano W, Suzuki M, Takagane A, Nakamura S. Analysis of microsatellite alterations in gastric carcinoma using the crypt isolation technique. J Pathol 2004 204:200 7.
27. Kobayashi K, Okamoto T, Takayama S, Akiyama M, Ohno T, Yamada H. Genetic instability in intestinal metaplasia is a frequent event leading to well-differentiated early adenocarcinoma of the stomach. Eur J Cancer 2000 36:1113 9.
28. Li YL, Tian Z, Wu DY, Fu BY, Xin Y. Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. World J Gastroenterol 2005 11:285 8.
29. Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study, 12th edn. Tokyo:Kinbara Publication, 1993.
30. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965 64:31 49.
31. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998 58:5248 57.
32. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996 20:1161 81.
33. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997 6:639 42.
34. Wong BC-Y, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004 291:187 94.
35. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994 54:5059 63.
36. Halling KC, Harper J, Moskaluk CA, et al. Origin of microsatellite instability in gastric cancer. Am J Pathol 1999 155:205 11.
37. Kang GH, Shim YH, Ro JY. Correlation of methylation of the hMLH1 promoter with lack of expression of hMLH1 in sporadic gastric carcinomas with replication error. Lab Invest 1999 79:903 9.
38. Fleisher AS, Esteller M, Wang S, et al. Hypermethylation of the hMLH1 promoter in human gastric cancers with microsatellite instability. Cancer Res 1999 59:1090 5.
39. Bonner RF, Emmert-Buck M, Cole K, et al. Laser capture microdissection: molecular analysis of tissue. Science 1997 278:1481 3.
40. Dillon D, Zheng K, Costa J. Rapid, efficient genotyping of clinical tumor samples by laser-capture microdissection/PCR/SSCP. Exp Mol Pathol 2001 70:195 200.
41. Cawkwell L, Li D, Lewis FA, et al. Microsatellite instability in colorectal cancer: Improved assessment using fluorescent polymerase chain reaction. Gastroenterology 1995 109:465 71.
42. Sung JJY, Lin S, Ching JYL, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000 119:7 14.
43. Sakaki N, Kozawa H, Egawa N, et al. Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings. Aliment Pharmacol Ther 2002 16:198 203.
44. Asaka M, Sugiyama T, Nobuta A, et al. Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 2001 6:294 9.
45. Leung WK, Sung JJ. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther 2002 16:1209 16.
46. Hibi K, Mitomi H, Koizumi W, et al. Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol 1997 108:26 34.
47. Jones NL, Shannon PT, Cutz E, et al. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997 151:1695 703.
48. Gong C, Mera R, Bravo JC, et al. KRAS mutations predict progression of preneoplastic gastric lesions. Cancer Epidemiol Biomarkers Prev 1999 8:167 71.
49. Hiyama T, Haruma K, Kitadai Y, et al. K-ras mutation in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer 2002 97:562 6.
50. Kang GH, Shim YH, Jung HY, et al. CpG island methylation in premalignant stage of gastric cancer. Cancer Res 2001 61:2847 51.
51. To KF, Keung WK, Lee TL, et al. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 2002 102:623 8.